CD6 is a cell surface receptor belonging to the scavenger receptor cysteine
-rich (SBCR) protein superfamily (SRCRSF), It specifically binds activated
leukocyte cell adhesion molecule (ALCAM, CD166), a member of the immunoglob
ulin (Ig) superfamily (IgSF). CD166 was among the first molecules identifie
d as a ligand for an SRCRSF receptor, and the CD6-CD166 interaction was the
first interaction characterized involving SRCRSF and IgSF proteins. We foc
us here on what has been learned about the specifics of the CD6-CD166 inter
action from in vitro analysis, The studies are thought to provide an instru
ctive example for the analysis of interactions between single-path transmem
brane cell surface proteins. Using soluble recombinant forms, the extracell
ular binding domains of receptor and ligand have been identified and charac
terized in a variety of assay systems. Both CD6 and CD166 have been subject
ed to intense mutagenesis and monoclonal antibody (mAb) binding studies and
residues critical for their interaction have been identified. The availabi
lity of structural prototypes of both superfamilies has made it possible to
map the binding site in CD166 and, more recently, in CD6 and compare these
regions to epitopes of mAbs that block, or do not block, the interaction.
In addition, the molecular basis of observed cross-species receptor-ligand
interactions could be rationalized. These studies illustrate the value of s
tructural templates for the interpretation of sequence and mutagenesis anal
yses. Proteins 2000;40:420-428. (C) 2000 Wiley-Liss, Inc.